Advrs effect of immune chkpt inhibtr/immunostim drugs, subs

This code indicates a patient is experiencing an unintended and harmful reaction to immune checkpoint inhibitors or other immunostimulant medications, and they are presenting for follow-up care or management of this reaction. These adverse effects can impact various organ systems due to the drugs' mechanism of enhancing the body's immune response.

Apply this code when a patient returns for ongoing treatment, monitoring, or management of an adverse effect that was previously diagnosed and is still active, stemming from immune checkpoint inhibitors or immunostimulant drugs. This is appropriate for subsequent visits related to conditions like immune-related colitis, pneumonitis, endocrinopathies, or dermatologic toxicities caused by these agents.

• Always sequence this code after the code for the specific adverse effect (e.g., K52.1 for toxic gastroenteritis).
• Ensure documentation clearly links the adverse effect to the immune checkpoint inhibitor or immunostimulant drug.
• Distinguish from initial encounters (T45.AX5A) or sequela (T45.AX5S) based on the encounter type.